The U.S. Food and Drug Administration Approves Pirtobrutinib (Jaypirca) for Relapsed/Refractory Mantle Cell Lymphoma
On January 27, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved pirtobrutinib…
News
The U.S. Food and Drug Administration Approves Zanubrutinib (Brukinsa) for Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL)
On January 19, the U.S. Food and Drug Administration (FDA) announced it has approved bruton tyrosine…
The U.S. Food and Drug Administration Approves Mosunetuzumab-axgb (Lunsumio) for Follicular Lymphoma
On December 22, 2022, the U.S. Food and Drug Administration (FDA) announced it has approved…
In Remembrance: Errol M. Cook
December 23, 2022 – It is with great sadness that the Lymphoma Research Foundation (LRF)…
Transforming Loss into Hope for Adolescents and Young Adults with Lymphoma
No parent should ever have to go through the excruciating experience of losing a child.…
Read the Latest Issue of Pulse: Fall 2022
Read the Fall 2022 edition of Pulse.
A Caregiver that Keeps on Giving
Roy Bridges has the type of life story you need to read to believe. Starting…
Mobile Health Technology Helps Blood Cancer Patients Navigate Diagnosis
These days, a cellphone is much more than just a phone – it’s a photo album, a GPS, a stereo system, an encyclopedia, a computer, a gaming system, a suite of tools all in the palm of your hand. One of the many tools that can be accessed via mobile technology are apps intended to help manage your health, sometimes known as mobile health technology.
Meet the Newly Elected LRF Scientific Advisory Board Members
The Lymphoma Research Foundation (LRF) welcomed three new members to its elite Scientific Advisory Board (SAB) on July 1. The new members represent distinct specialties that will contribute to the global impact of the Foundation.
Where Are They Now? Paolo Strati, MD
Where Are They Now? Paolo Strati, MD When did you become interested in the study…
Stay informed with news, alerts and other resources.
